Pathogenic variants in SCN5A, the gene encoding the cardiac sodium channel Nav1.5, are implicated in two distinct electrophysiological disorders: Brugada syndrome, associated with loss-of-function mutations, and long QT syndrome type 3 (LQT3), caused by gain-of-function variants. This evidence concerns the gene SCN5A and Brugada syndrome.